# Inpatient Penicillin Allergy Delabeling Study

> **NCT05020327** · PHASE4 · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Penicillin Allergy
- Penicillin Sensitivity
- Penicillin Reaction
- Penicillin Intolerance

## Interventions

- **DRUG:** Graded Oral Amoxicillin Challenge
- **OTHER:** De-labelling in electronic medical record
- **OTHER:** Referral to Allergy Immunology/Retention of Allergy Label

## Key facts

- **NCT ID:** NCT05020327
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-22
- **Primary completion:** 2022-03-30
- **Final completion:** 2022-03-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05020327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05020327, "Inpatient Penicillin Allergy Delabeling Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05020327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*